The MoneyTree™ Report is a quarterly study of venture capital investment activity in the United States. As a collaboration between PricewaterhouseCoopers and the National Venture Capital Association based upon data from Thomson Reuters, it is the only industry-endorsed research of its kind.
For the most recent quarter's results including VC and company lists, as well as aggregate trend data dating back to 1995, visit our interactive MoneyTree Report site: pwcmoneytree.com
Third quarter Technology venture capital investment increased 23 percent year-over-year but fell 25 percent quarter-over-quarter.
Cleantech received $366 million in 32 venture deals in the third quarter of 2014. Funding dollars increased 25 percent year-over-year, while deal volume decreased 27 percent over the same period.
Q3 2014 Biotech trending high
Investments in both the biotech and medical devices industries have continued to increase year-over-year. However, investments for the two industries declined compared to the exceptionally strong last quarter, which saw record high investments.
With technology and innovation coming of age in many emerging countries, these fast-growing markets are important destinations for private equity. Together with our US MoneyTree™ Report, these reports will help you compare trends in various parts of the world and provide a truly global view of VC/PE investments. The global MoneyTree reports serve as a reliable source of current and recent trends in PE/VC funding for: Israel, India, Russia and China.